Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer’s disease in T2DM patients

Endocrine

Volumn 53, Issue 2, 2016, Pages 350-363

  Bertram, Sebastian ^a   Brixius, Klara ^a   Brinkmann, Christian ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Alzheimer s disease; Dementia; Exercise; Training; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; CERAMIDE; OLIGOMER; SOMATOMEDIN; TESTOSTERONE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; BLOOD PRESSURE REGULATION; BRAIN CAPILLARY; CELL FUNCTION; CHRONIC INFLAMMATION; CLINICAL FEATURE; DIABETOGENESIS; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSLIPIDEMIA; ENDOTHELIUM; EXERCISE; HUMAN; INSULIN RESISTANCE; MEMORY; MICROANGIOPATHY; MOLECULAR INTERACTION; MOLECULAR MODEL; MULTIINFARCT DEMENTIA; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TRAINING; UPREGULATION; VASCULAR DISEASE; COMPLICATION; DEMENTIA; KINESIOTHERAPY; PROCEDURES;

ALZHEIMER DISEASE; DEMENTIA; DIABETES MELLITUS, TYPE 2; EXERCISE; EXERCISE THERAPY; HUMANS;

EID: 84966457760     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-016-0976-8     Document Type: Review

References (160)

1. J. Li, Y.H. Shao, Y.P. Gong, Y.H. Lu, Y. Liu, C.L. Li, Diabetes mellitus and dementia—a systematic review and meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 18, 1778–1789 (2014)
2. M. Baumgart, H.M. Snyder, M.C. Carrillo, S. Fazio, H. Kim, H. Johns, Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 11, 718–726 (2015)
3. P. Palta, A.L. Schneider, G.J. Biessels, P. Touradji, F. Hill-Briggs, Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J. Int. Neuropsychol. Soc. 20, 278–291 (2014)
4. S. Sadanand, R. Balachandar, S. Bharath, Memory and executive functions in persons with type 2 diabetes: a meta-analysis. Diabetes Metab. Res. Rev. 32, 132–142 (2016)
5. C. Vincent, P.A. Hall, Executive function in adults with type 2 diabetes: a meta-analytic review. Psychosom. Med. 77, 631–642 (2015)
6. C. Moran, T.G. Phan, J. Chen, L. Blizzard, R. Beare, A. Venn, G. Münch, A.G. Wood, J. Forbes, T.M. Greenaway, S. Pearson, V. Srikanth, Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 36, 4036–4042 (2013)
7. C. Cooper, A. Sommerlad, C.G. Lyketsos, G. Livingston, Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am. J. Psychiatry 172, 323–334 (2015)
8. R.O. Roberts, D.S. Knopman, Y.E. Geda, R.H. Cha, V.S. Pankratz, L. Baertlein, B.F. Boeve, E.G. Tangalos, R.J. Ivnik, M.M. Mielke, R.C. Petersen, Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement. 10, 18–26 (2014)
9. X.F. Meng, J.T. Yu, H.F. Wang, M.S. Tan, C. Wang, C.C. Tan, L. Tan, Midlife vascular risk factors and the risk of Alzheimer’s disease: a systematic review and meta-analysis. J. Alzheimers Dis. 42, 1295–1310 (2014)
10. J.Q. Li, L. Tan, H.F. Wang, M.S. Tan, L. Tan, W. Xu, Q.F. Zhao, J. Wang, T. Jiang, J.T. Yu, Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies. J. Neurol. Neurosurg. Psychiatry. 87, 476–484 (2015)
11. K. Gudala, D. Bansal, F. Schifano, A. Bhansali, Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J. Diabetes Investig. 4, 640–650 (2013)
12. S. Norton, F.E. Matthews, D.E. Barnes, K. Yaffe, C. Brayne, Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 13, 788–794 (2014)
13. J.T. O’Brien, A. Thomas, Vascular dementia. Lancet 386, 1698–1706 (2015)
14. C. Zhiyou, W. Chuanling, H. Wenbo, T. Hanjun, T. Zhengang, X. Ming, Y. Liang-Jun, Cerebral small vessel disease and Alzheimer’s disease. Clin. Interv. Aging 10, 1695–1704 (2015)
15. P. Rajendran, T. Rengarajan, J. Thangavel, Y. Nishigaki, D. Sakthisekaran, G. Sethi, I. Nishigaki, The vascular endothelium and human diseases. Int. J. Biol. Sci. 9, 1057–1069 (2013)
16. X.-L. Tan, Y.-Q. Xue, T. Ma, X. Wang, J.J. Li, L. Lan, K.U. Malik, M.P. McDonald, A.M. Dopico, F.-F. Liao, Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Mol. Neurodegener. 7, 273 (2015)
17. R.H. Swerdlow, Is aging part of Alzheimer’s disease, or is Alzheimer’s disease part of aging? Neurobiol. Aging 28, 1465–1480 (2007)
18. S.M. de la Monte, J.R. Wands, Alzheimer’s disease is type 3 diabetes—evidence reviewed. J. Diabetes Sci. Technol. 2, 1101–1113 (2008)
19. J. Attems, K.A. Jellinger, The overlap between vascular disease and Alzheimer’s disease—lessons from pathology. BMC Med. 11, 206 (2014)
20. F. Paneni, J.A. Beckman, M.A. Creager, F. Cosentino, Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur. Heart J. 34, 2436–2443 (2013)
21. M.A. Creager, T.F. Luscher, F. Cosentino, J.A. Beckman, Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108, 1527–1532 (2003)
22. P. Geraldes, G.L. King, Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res. 106, 1319–1331 (2010)
23. A.L. Vinik, T. Erbas, T.S. Park, R. Nolan, G.L. Pittenger, Platelet dysfunction in type 2 diabetes. Diabetes Care 24, 1476–1485 (2001)
24. M. Lee, J.L. Saver, A. Towfighi, J. Chow, B. Ovbiagele, Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis. Atherosclerosis 217, 492–498 (2011)
25. Z.Y. Li, P. Wang, C.Y. Miao, Adipokines in inflammation, insulin resistance and cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 38, 888–896 (2011)
26. A.C. Montezano, M. Dulak-Lis, S. Tsiropoulou, A. Harvey, A.M. Briones, R.M. Touyz, Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can. J. Cardiol. 31, 631–641 (2015)
27. L.P. van der Heide, G.M. Ramakers, M.P. Schmidt, Insulin signaling in the central nervous system: learning to survive. Prog. Neurobiol. 79, 2005–2021 (2006)
28. F.T. Boyd, D.W. Clarke, T.F. Muther, M.K. Raizada, Insulin receptors and insulin modulation of norepinephrine uptake in neuronal cultures from rat brain. J. Biol. Chem. 260, 15880–15884 (1985)
29. E.D. Martín, A. Sánchez-Perez, J.L. Trejo, J.A. Martin-Aldana, M. Cano-Jaimez, S. Pons, C. Acosta Umanzor, L. Menes, M.F. White, D.J. Burks, IRS-2 deficiency impairs NMDA receptor-dependent long-term potentiation. Cereb. Cortex 22, 1717–1727 (2012)
30. D.A. Costello, M. Claret, H. Al-Qassab, F. Plattner, E.E. Irvine, A.l. Choudhury, K.P. Giese, D.J. Withers, P. Pedarzani, Brain deletion of insulin receptor substrate 2 disrupts hippocampal synaptic plasticity and metaplasticity. PLoS One 7, e31124 (2012)
31. E.M. Bingham, D. Hopkins, D. Smith, A. Pernet, W. Hallett, L. Reed, P.K. Marsden, S.A. Amiel, The role of insulin in human brain glucose metabolism: an 18-fluoro-deoxyglucose positron emission tomography study. Diabetes 51, 3384–3390 (2002)
32. B. Cholerton, L.D. Baker, S. Craft, Insulin, cognition and dementia. Eur. J. Pharmacol. 719, 170–179 (2013)
33. G. Bedse, F. Di Domenico, G. Serviddio, T. Cassano, Aberrant insulin signaling in Alzheimer’s disease: current knowledge. Front. Neurosci. 16, 204 (2015)
34. J.M. Duarte, Metabolic alterations associated to brain dysfunction in diabetes. Aging Dis. 6, 304–321 (2015)
35. R. Sandhir, S. Gupta, Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: a critical appraisal. World J. Diabetes 6, 1223–1242 (2015)
36. K. Talbot, H. Wang, H. Kazi, L. Han, K.P. Bakshi, A. Stucky, R.L. Fuino, K.R. Kawaguchi, A.J. Samoyedny, R.S. Wilson, Z. Arvanitakis, J.A. Schneider, B.A. Wolf, D.A. Bennett, J.Q. Trojanowski, S.E. Arnold, Demonstrated brain insulin resistance in AD patients is associated with IGF-1 resistance, IRS-1 dysregulation and cognitive decline. J. Clin. Investig. 122, 1316–1338 (2012)
37. K.D. Copps, M.F. White, Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55, 2565–2582 (2012)
38. L. Mosconi, Glucose metabolism in normal aging and Alzheimer’s disease: methodological and physiological considerations for PET studies. Clin. Transl. Imaging 1, 217–233 (2013)
39. T.R. Bomfim, L. Forny-Germano, L.B. Sathler, J. Brito-Moreira, J.C. Houzel, H. Decker, M.A. Silverman, H. Kazi, H.M. Melo, P.L. McClean, C. Holscher, S.E. Arnold, K. Talbot, W.L. Klein, D.P. Munoz, S.T. Ferreira, F.G. De Felice, An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers. J. Clin. Investig. 122, 1339–1353 (2012)
40. J. Freiherr, M. Hallschmid, W.H. Frey II, Y.F. Brünner, C.D. Chapman, C. Hölscher, S. Craft, F.G. De Felice, C. Benedict, Intranasal insulin as a treatment for Alzheimer’s disease: a review of basic research and clinical evidence. CNS Drugs 27, 505–514 (2013)
41. C.R. Weston, R.J. Davis, The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19, 142–149 (2007)
42. S. Chakrabarti, V.K. Khemka, A. Banerjee, G. Chatterjee, A. Ganguly, A. Biswas, Metabolic risk factors of sporadic Alzheimer’s disease: implications in the pathology, pathogenesis, and treatment. Aging Dis. 6, 282–299 (2015)
43. G. Pandini, V. Pace, A. Copani, S. Squatrito, D. Milardi, R. Vigneri, Insulin has multiple antiamyloidogenic effects on human neuronal cells. Endocrinology 154, 375–387 (2013)
44. H.W. Querfurth, F.M. LaFarla, Alzheimer’s disease. NEJM 362, 329–344 (2010)
45. A. Serrano-Pozo, M.P. Frosch, E. Masliah, B.T. Hyman, Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 1(1), a006189 (2011)
46. M. Perluigi, G. Pupo, A. Tramutola, C. Cini, R. Coccia, E. Barone, E. Head, D.A. Butterfield, F. Di Domenico, Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain. Biochim. Biophys. Acta 1842, 1144–1153 (2014)
47. W.Q. Zhao, P.N. Lacor, H. Chen, M.P. Lambert, M.J. Quon, G.A. Krafft, W.L. Klein, Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}. J. Biol. Chem. 284, 18742–18753 (2009)
48. A. Perez, L. Morelli, J.C. Cresto, E.M. Castano, Degradation of soluble amyloid β-peptides 1-40, 1-42, and the Dutch variant 1-40q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem. Res. 25, 247–255 (2000)
49. A. Jayaraman, C.J. Pike, Alzheimer’s disease and type 2 diabetes: multiple mechanisms contribute to interactions. Curr. Diabetes Rep. 14, 476 (2014)
50. N.M. Ashpole, J.E. Sanders, E.L. Hodges, H. Yan, W.E. Sonntag, Growth hormone, insulin-like growth factor-1 and the aging brain. Exp. Gerontol. 68, 76–81 (2015)
51. P.N. Lacor, M.C. Buniel, P.W. Furlow, A.S. Clemente, P.T. Velasco, M. Wood, K.L. Viola, W.L. Klein, Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J. Neurosci. 27, 796–807 (2007)
52. F.G. De Felice, Alzheimer’s disease and insulin resistance: translating basic science into clinical applications. J. Clin. Investig. 123, 531–539 (2013)
53. N. Rajkovic, M. Zamaklar, K. Lalic, A. Jotic, L. Lukic, T. Milicic, S. Singh, L. Stosic, N.M. Lalic, Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention. Int. J. Environ. Res. Public Health 11, 4049–4065 (2014)
54. T. Reinehr, B. Karges, T. Meissner, S. Wiegand, B. Stoffel-Wagner, R.W. Holl, J. Woelfle, Inflammatory markers in obese adolescents with type 2 diabetes and their relationship to hepatokines and adipokines. J. Pediatr. (2016). doi:10.1016/j.jpeds.2016.02.055
55. J. Spranger, A. Kroke, M. Möhlig, K. Hoffmann, M.M. Bergmann, M. Ristow, H. Boeing, A.F. Pfeiffer, Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC) Potsdam Study. Diabetes 52, 812–817 (2003)
56. R. Cacabelos, M. Barguero, P. Garcia, X.A. Alvarez, E. Varela de Seijas, Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer’s disease and neurological disorders. Methods Find. Exp. Clin. Pharmacol. 13, 455–458 (1991)
57. O.V. Forlenza, B.S. Diniz, L.L. Talib, V.A. Mendonca, E.B. Ojopi, W.F. Gattaz, A.L. Teixeira, Increased serum IL-1beta level in Alzheimer’s disease and mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 28, 507–512 (2009)
58. J.P. Jia, R. Meng, Y.X. Sun, W.J. Sun, X.M. Ji, L.F. Jia, Cerebrospinal fluid tau, abeta1-42 and inflammatory cytokines in patients with Alzheimer’s disease and vascular dementia. Neurosci. Lett. 383, 12–16 (2005)
59. K. Wada-Isoe, Y. Wakutani, K. Urakami, K. Nakashima, Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol. Scand. 110, 124–127 (2004)
60. M.C. Arkan, A.L. Hevener, F.R. Greten, S. Maeda, Z.W. Li, J.M. Long, A. Wynshaw-Boris, G. Poli, J. Olefsky, M. Karin, IKK-beta links inflammation to obesity induced-insulin-resistance. Nat. Med. 11, 191–198 (2005)
61. B. de Roos, V. Rungapamestry, K. Ross, G. Rucklidge, M. Reid, G. Duncan, G. Horgan, S. Toomey, J. Browne, C.E. Loscher, K.H. Mills, H.M. Roche, Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high fat diet. Proteomics 9, 3244–3256 (2009)
62. Q.L. Ma, F. Yang, E.R. Rosario, O.J. Ubeda, W. Beech, D.J. Gant, P.P. Chen, B. Hudspeth, C. Chen, X. Zhao, H.V. Vinters, S.A. Frautschy, G.M. Cole, Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun-N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J. Neurosci. 29, 9078–9089 (2009)
63. N.K. Acharya, E.C. Levin, P.M. Clifford, M. Han, R. Tourtellotte, D. Chamberlain, M. Pollaro, N.J. Coretti, M.C. Kosciuk, E.P. Nagele, C. Demarshall, T. Freeman, Y. Shi, C. Guan, C.H. Macphee, R.L. Wilensky, R.G. Nagele, Diabetes and hypercholesterolemia increase blood–brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib. J. Alzheimers Dis. 35, 179–198 (2013)
64. S. Takeda, N. Sato, R. Morishita, Systemic inflammation, blood–brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer’s disease: relevance to pathogenesis and therapy. Front. Aging Neurosci. 6, 171 (2014)
65. S. Takeda, N. Sato, K. Ikimura, H. Nishino, H. Rakugi, R. Morishita, Increased blood–brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiol. Aging 34, 2064–2070 (2014)
66. J.A. Sonnen, E.B. Larson, K. Brickell, P.K. Crane, R. Woltjer, T.J. Montine, S. Craft, Different patterns of cerebral injury in dementia with or without diabetes. Arch. Neurol. 66, 315–322 (2009)
67. I.A.C. Arnoldussen, A.J. Kiliaan, D.R. Gustafson, Obesity and dementia. Eur. Neuropsychopharmacol. 23, 1982–1999 (2014)
68. E.M.A. Vasconcelos, G.R. Degasperi, H.C.F. de Oliveira, A.E. Vercesi, E.C. de Faria, L.N. Castilho, Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients. Clin. Biochem. 42, 1222–1227 (2009)
69. S.P. Wolff, R.T. Dean, Glucose autoxidation and protein modification. Biochem. J. 245, 243–250 (1987)
70. X. Du, T. Matsumura, D. Edelstein, L. Rosetti, Z. Zsengeller, C. Szabo, M. Brownlee, Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Investig. 112, 1049–1057 (2003)
71. F. Di Domenico, G. Pupo, E. Giraldo, M.C. Badia, P. Monllor, A. Lloret, M. Eugenia Schinina, A. Giorgi, C. Cini, A. Tramutola, D.A. Butterfield, J. Vina, M. Perluigi, Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients. Free Radic. Biol. Med. 91, 1–9 (2016)
72. M.A. Pappolla, R.A. Omar, K.S. Kim, N.K. Robakis, Immunohistochemical evidence of oxidative stress in Alzheimer’s disease. Am. J. Pathol. 140, 621–628 (1992)
73. F.G. De Felice, M.N.N. Viera, T.R. Bomfirm, H. Decker, P.T. Velasco, M.P. Lambert, K.L. Viola, W. Zhao, S.T. Ferreira, W.L. Klein, protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Aβ oligomers. Proc. Natl Acad. Sci. USA 106, 1971–1976 (2009)
74. J.V. Cross, D.J. Templeton, Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem. J. 381, 675–683 (2004)
75. V. Aguirre, T. Uchida, L. Yenush, R. Davis, M.F. White, The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser-307. J. Biol. Chem. 275, 9047–9054 (2000)
76. C. Bonnard, A. Durand, S. Peyrol, E. Chanseaume, M. Chauvin, B. Morio, H. Vidal, J. Rueusset, Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Investig. 118, 789–800 (2008)
77. F.G. De Felice, S.T. Ferreira, Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes 63, 2262–2272 (2014)
78. A. Grimm, K. Friedland, A. Eckert, Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s disease. Biogerontology 17, 281–296 (2016)
79. G. Schreibelt, G. Kooij, A. Reijerkek, R. van Doorn, S.I. Gringhuis, S. van der Pol, B.B. Weksler, I.A. Romero, P. Couraud, J. Piontek, I.E. Blasig, C.D. Dijkstra, E. Ronken, H.E. de Vries, Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 21, 3666–3676 (2007)
80. A. Goldin, J.A. Beckman, A.M. Schmidt, M.A. Creager, Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114, 597–605 (2006)
81. M. Pansuria, H. Xi, L. Li, X.F. Yang, H. Wang, Insulin resistance, metabolic stress, and atherosclerosis. Front. Biosci. (Sch. Ed.) 4, 916–931 (2012)
82. R. Deane, S. Du Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A.M. Schmidt, D.L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern, B. Zlokovic, RAGE mediates amyloid-beta peptide transport across the blood–brain barrier and accumulation in brain. Nat. Med. 9, 907–913 (2003)
83. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, A.M. Schmidt, RAGE and amyloid-beta peptide neurotoxicity in Alzheimer’s disease. Nature 382, 685–691 (1996)
84. P. Seubert, C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schlossmacher, J. Whaley, C. Swindlehurst, R. McCormack, R. Wolfert, D. Selkoe, I. Lieberburg, D. Schenk, Isolation and quantification of soluble Alzheimer’s beta-peptide from biological fluids. Nature 359, 325–327 (1992)
85. M.A. Erickson, W.A. Banks, Blood–brain barrier dysfunction as a cause and consequence of Alzheimer’s disease. J. Cereb. Blood Flow Metab. 33, 1500–1513 (2013)
86. L.F. Lue, D.G. Walker, L. Brachova, T.G. Beach, J. Rogers, A.M. Schmidt, D.M. Stern, S.D. Yan, Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer’s disease: identification of a cellular activation mechanism. Exp. Neurol. 171, 29–45 (2001)
87. E.E. Jones, S. Dworski, D. Canals, J. Casas, G. Fabrias, D. Schoenling, T. Levade, C. Denlinger, Y.A. Hannun, J.A. Medin, R.R. Drake, On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Anal. Chem. 86, 8303–8311 (2014)
88. W.L. Holland, B.T. Bikman, L.P. Wang, G. Yuguang, K.M. Sargent, S. Bulchand, T.A. Knotts, G. Shui, D.J. Clegg, M.R. Wenk, M.J. Pagliassotti, P.E. Scherer, S.A. Summers, Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Investig. 121, 1858–1870 (2011)
89. W.L. Holland, T.A. Knotts, J.A. Chavez, L.P. Wang, K.L. Hoehn, S.A. Summers, Lipid mediators of insulin clearance. Nutr. Rev. 65, 39–46 (2007)
90. S.M. de la Monte, Triangulated mal-signaling in Alzheimer’s disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed. J. Alzheimers Dis. 30, 231–249 (2012)
91. L.E. Lynn-Cook, M. Lawton, M. Tong, E. Silbermann, L. Longato, P. Jiao, P. Mark, J.R. Wands, H. Xu, S.M. de la Monte, Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. J. Alzheimers Dis. 16, 715–729 (2009)
92. S.M. de la Monte, M. Tong, V. Nguyen, M. Setshedi, L. Longato, J.R. Wands, Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. J. Alzheimers Dis. 21, 967–984 (2010)
93. J. Ghiso, M. Shayo, M. Calero, D. Ng, Y. Tomidokoro, S. Gandy, A. Rostagno, B. Frangione, Systemic catabolism of Alzheimer’s Abeta40 and Abeta42. J. Biol. Chem. 279, 45897–45908 (2004)
94. S. Ito, S. Ohtsuki, J. Kamiie, Y. Nezu, T. Terasaki, Cerebral clearance of human amyloid-beta peptide (1-40) across the blood–brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes. J. Neurochem. 103, 2482–2490 (2007)
95. C. Tamaki, S. Ohtsuki, T. Terasaki, Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1-40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes. Mol. Pharmacol. 72, 850–855 (2007)
96. M. Grossmann, M.C. Thomas, S. Panagiotopoulos, K. Sharpe, R.J. Macisaac, S. Clarke, J.D. Zajac, G. Jerums, Low testosterone levels are common and associated with insulin resistance in men with diabetes. J. Clin. Endocrinol. Metab. 93, 1834–1840 (2008)
97. D. Kapoor, E. Goodwin, K.S. Channer, T.H. Jones, Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol. 154, 899–906 (2006)
98. M. Grossmann, R. Hoermann, G. Wittert, B.B. Yeap, Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Clin. Endocrinol. (Oxf.) 83, 344–351 (2015)
99. E. Hogervorst, J. Williams, M. Budge, L. Barnetson, M. Combrinck, A.D. Smith, Serum total testosterone is lower in men with Alzheimer’s disease. Neuroendocrinol. Lett. 22, 163–168 (2001)
100. E.R. Rosario, L. Chang, F.Z. Stanczyk, C.J. Pike, Age-related testosterone depletion and the development of Alzheimer disease. JAMA 292, 1431–1432 (2004)
101. R.S. Tan, Testosterone effect on brain metabolism in elderly patients with Alzheimer’s disease: comparing two cases at different disease stages. Aging Clin. Exp. Res. 25, 343–347 (2013)
102. E. Teixeira-Lemos, S. Nunes, F. Teixeira, F. Reis, Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc. Diabetol. 28(10), 12 (2011)
103. N.G. Boulè, E. Haddad, G.P. Kenny, G.A. Wells, R.J. Sigal, Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a metaanalysis of controlled clinical trials. JAMA 286, 1218–1227 (2001)
104. N.G. Boulè, G.P. Kenny, E. Hadda, G.A. Wells, R.J. Sigal, Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 46, 1071–1081 (2003)
105. I.M. Stratton, A.I. Adler, H.A. Neil, D.R. Matthews, S.E. Manley, C.A. Cull, D. Hadden, R.C. Turner, R.R. Holman, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) prospective observational study. BMJ 321, 405–412 (2000)
106. R. Rubinshtein, J.T. Kuvin, M. Soffler, R.J. Lennon, S. Lavi, R.E. Nelson, G.M. Pumper, L.O. Lerman, A. Lerman, Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur. Heart J. 31, 1142–1148 (2010)
107. J. Yeboah, A.R. Folsom, G.L. Burke, C. Johnson, J.F. Polak, W. Post, J.A. Lima, J.R. Crouse, D.M. Herrington, Perdictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120, 502–509 (2009)
108. B.C.S. Boa, M.C. Souza, R.D. Leite, S.V. da Silva, T.C. Barja-Fidalgo, L.G. Kraemer-Aguiar, E. Bouskela, Chronic aerobic exercise associated to dietary modification improve endothelial function and eNOS expression in high fat fed hamsters. PLoS One 18, e102554 (2014)
109. A. Maiorana, G. O’Driscoll, C. Cheetham, L. Dembo, K. Stanton, C. Goodman, R. Taylor, D. Green, The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. J. Am. Coll. Cardiol. 38, 850–856 (2001)
110. S. Okada, A. Hiuge, H. Makino, A. Nagumo, H. Takaki, H. Konishi, Y. Goto, Y. Yoshimasa, Y. Myamoto, Effect of exercise intervention on endothelial function and incidence of cardiovascular disease in patients with type 2 diabetes. J. Atheroscler. Thromb. 17, 828–833 (2010)
111. N.D. Cohen, D.W. Dunstan, C. Robinson, E. Vulikh, P.Z. Zimmet, J.E. Shaw, Improved endothelial function following a 14-month resistance exercise training program in adults with type 2 diabetes. Diabetes Res. Clin. Pract. 79, 405–411 (2008)
112. V.A. Cornelissen, R.H. Fagard, Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 46, 667–675 (2005)
113. Y. Hayashino, J.L. Jackson, N. Fukumori, F. Nakamura, S. Fukuhara, Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Diabetes Res. Clin. Pract. 98, 349–360 (2012)
114. R.A. Swain, A.B. Harris, E.C. Wiener, M.V. Dutka, H.D. Morris, B.E. Theien, S. Konda, K. Engberg, P.C. Lauterbur, W.T. Greenough, Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience 117, 1037–1046 (2003)
115. S. Wang, L. Chen, L. Zhang, C. Huang, Y. Xiu, F. Wang, C. Zhou, Y. Luo, Q. Xiao, Y. Tang, Effects of long-term exercise on spatial learning, memory ability, and cortical capillaries in aged rats. Med. Sci. Monit. 21, 945–954 (2015)
116. Y. Ding, J. Li, Y.H. Ding, Q. Lai, J.A. Rafols, J.W. Phillis, J.C. Clark, F.G. Diaz, Exercise pre-conditioning reduces brain damage in ischemic rats that may be associated with regional angiogenesis and cellular overexpression of neurotrophin. Neuroscience 124, 538–591 (2004)
117. D. Aarsland, F.S. Sardahaee, S. Anderssen, C. Ballard, Alzheimer’s Society Systematic Review Group: Is physical activity a potential preventive factor for vascular dementia? A systematic review. Aging Ment. Health 14, 386–395 (2010)
118. J. Andersson, J.H. Jansson, G. Hellsten, T.K. Nilsson, G. Hallmans, K. Boman, Effects of heavy endurance physical exercise on inflammation markers in non-athletes. Atherosclerosis 209, 601–605 (2010)
119. C. Kasapis, P.D. Thompson, The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J. Am. Coll. Cardiol. 45, 1563–1569 (2005)
120. C.B. Papini, P.M. Nakamura, L.P. Zorzetto, J.L. Thompson, A.C. Phillips, E. Kokubun, The effect of a community-based, primary health care exercise program on inflammatory biomarkers and hormone levels. Mediat. Inflamm 2014, 185707 (2014)
121. A.C. McKee, D.H. Daneshvar, V.E. Alvarez, T.D. Stein, The neuropathology of sport. Acta Neuropathol. 127, 29–51 (2014)
122. S.M. Abd El-Kader, Aerobic versus resistance exercise training in modulation of insulin resistance, adipocytokines and inflammatory cytokine levels in obese type 2 diabetic patients. J. Adv. Res. 2, 179–183 (2011)
123. S. Balducci, S. Zanuso, A. Nicolucci, F. Fernando, S. Cavallo, P. Cardelli, S. Fallucca, E. Alessi, C. Letizia, A. Jimenez, F. Fallucca, G. Pugliese, Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr. Metab. Cardiovasc. Dis. 20, 608–617 (2010)
124. M. Straczkowski, I. Kowalska, S. Dzienis-Straczkowska, A. Stepién, E. Skibinska, M. Szelachowska, I. Kinalska, Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance. Eur. J. Endocrinol. 145, 273–280 (2001)
125. I. Giannopoulou, B. Fernhall, R. Carhart, R.S. Weinstock, T. Baynard, A. Figueroa, J.A. Kanaley, Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 54, 866–875 (2005)
126. N.P. Kadoglou, F. Iliadis, N. Angelopoulou, D. Perrea, G. Ampaatzidis, C.D. Liapis, M. Alevizos, The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur. J. Cardiovasc. Prev. Rehabil. 14, 837–843 (2007)
127. A. Nguyen, N. Duquette, M. Mamarbachi, E. Thorin, Epigenetic regulatory effect of exercise on glutathione peroxidase 1 expression in the skeletal muscle of severely dyslipidemic mice. PLoS One 17(10), e0142287 (2016)
128. Z. Qi, J. He, Y. Zhang, Y. Shao, S. Ding, Exercise training attenuates oxidative stress and decreases p53 protein content in skeletal muscle of type 2 diabetic Goto–Kazaki rats. Free Radic. Biol. Med. 50, 794–800 (2011)
129. M.C. Gomez-Cabrera, E. Domenech, J. Vina, Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. Free Radic. Biol. Med. 44, 126–131 (2008)
130. L.L. Ji, Modulation of skeletal muscle antioxidant defense by exercise: role of redox signaling. Free Radic. Biol. Med. 44, 142–152 (2008)
131. R.T. Iborra, I.C. Ribeiro, M.Q. Neves, A.M. Charf, S.A. Lottenberg, C.E. Negrao, E.R. Nakandakare, M. Passarelli, Aerobic exercise training improves the role of high-density lipoprotein antioxidant and reduces plasma lipid peroxidation in type 2 diabetes mellitus. Scand. J. Med. Sci. Sports 18, 742–750 (2008)
132. G. Lazarevic, S. Antic, T. Cvetkovic, V. Djordjevic, P. Vlahovic, V. Stefanovic, Effects of regular exercise on cardiovascular risk factors profile and oxidative stress in obese type 2 diabetic patients in regard to SCORE risk. Acta Cardiol. 63, 485–491 (2008)
133. C.K. Roberts, D. Won, S. Pruthi, S.S. Lin, R.J. Barnard, Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men. Diabetes Res. Clin. Pract. 73, 249–259 (2006)
134. T.P. Wycherley, G.D. Brinkworth, M. Noakes, J.D. Buckley, P.M. Clifton, Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes. Diabetes Obes. Metab. 10, 1062–1073 (2008)
135. S. Kurban, I. Mehmetoglu, J.F. Yerlikaya, S. Gönen, S. Erdem, Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus. Endocr. Res. 36, 116–123 (2011)
136. Z. Radak, M. Sasvari, C. Nyakas, T. Kaneko, S. Tahara, H. Ohno, S. Goto, Single bout of exercise eliminates the immobilization-induced oxidative stress in rat brain. Neurochem. Int. 39, 33–38 (2001)
137. A.E. Speck, C.B. Tromm, B.G. Pozzi, C.S. Paganini, T. Tuon, P.C. Silveira, A.S. Aguiar Jr., R.A. Pinho, The dose-dependent antioxidant effects of physical exercise in the hippocampus of mice. Neurochem. Res. 39, 1496–1501 (2014)
138. S. Bayod, C. Guzmán-Brambila, S. Sanchez-Roige, J.F. Lalanza, P. Kaliman, D. Ortuno-Sahagun, R.M. Escorihuela, M. Pallàs, Voluntary exercise promotes beneficial anti-aging mechanisms in SAMP8 female brain. J. Mol. Neurosci. 55, 525–532 (2015)
139. J.J. Dubé, F. Amati, F.G.S. Toledo, M. Stefanovic-Racic, A. Rossi, P. Coen, B.H. Goodpaster, Effect of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia 54, 1147–1156 (2011)
140. 14:0 ceramide in obesity and type 2 diabetes. Obesity 23, 1414–1421 (2015)
141. T.W. Lin, Y.H. Shih, S.J. Chen, C.H. Lien, C.Y. Chang, T.Y. Huang, S.H. Chen, C.J. Jen, Y.M. Kuo, Running exercise delays neurodegeneration in amygdala and hippocampus of Alzheimer’s disease (APP/PS1) transgenic mice. Neurobiol. Learn. Mem. 118, 189–197 (2015)
142. L.A. Consitt, J.L. Copeland, M.S. Tremblay, Endogenous anabolic hormone responses to endurance versus resistance exercise and training in women. Sports Med. 32, 1–22 (2002)
143. R.M. Daly, D.W. Dunstan, N. Owen, D. Jolley, J.E. Shaw, P.Z. Zimmet, Does high-intensity resistance training maintain bone mass during moderate weight loss in older overweight adults with type 2 diabetes? Osteoporos. Int. 16, 1703–1712 (2005)
144. J. Ibanez, M. Izquierdo, I. Arguelles, L. Forga, J.L. Larrión, M. García-Unciti, F. Idoate, E.M. Gorostiaga, Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes Care 28, 662–667 (2005)
145. C.W. Cotman, N.C. Berchtold, L.A. Christie, Exercise builds brain health. Key roles of growth factor cascades and inflammation. Trends Neurosci. 30, 464–472 (2007)
146. C.H. Hillman, K.I. Erickson, A.F. Kramer, Be smart, exercise your heart. Exercise effects on brain and cognition. Nat. Rev. Neurosci. 9, 58–65 (2008)
147. T. Huang, K.T. Larsen, M. Ried-Larsen, N.C. Møller, L.B. Andersen, The effects of physical activity and exercise on brain-derived neurotrophic factor in healthy humans. A review. Scand. J Med. Sci. Sports 24, 1–10 (2014)
148. D.K. Binder, H.E. Scharfman, Brain-derived neurotrophic factor. Growth Factors 22, 123–131 (2004)
149. K. Marosi, M.P. Mattson, BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol. Metab. 25, 89–98 (2014)
150. B.K. Pedersen, Muscles and their myokines. J. Exp. Biol. 214, 337–346 (2010)
151. C. Zuccato, E. Cattaneo, Brain-derived neurotrophic factor in neurodegenerative diseases. Nat. Rev. Neurol. 5, 311–322 (2009)
152. K. Knaepen, M. Goekint, E.M. Heyman, R. Meeusen, Neuroplasticity—exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Med. 40, 765–801 (2010)
153. V.B. Matthews, M.-B. Åström, M.H.S. Chan, C.R. Bruce, K.S. Krabbe, O. Prelovsek, T. Åkerström, C. Yfanti, C. Broholm, O.H. Mortensen, M. Penkowa, P. Hojman, A. Zankari, M.J. Watt, H. Bruunsgaard, B.K. Pedersen, M.A. Febbraio, Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 52, 1409–1418 (2009)
154. P. Rasmussen, P. Brassard, H. Adser, M.V. Pedersen, L. Leick, E. Hart, N.H. Secher, B.K. Pedersen, H. Pilegaard, Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp. Physiol. 94, 1062–1069 (2009)
155. G.S. Griesbach, D.A. Hovda, F. Gomez-Pinilla, Exercise-induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activation. Brain Res. 1288, 105–115 (2009)
156. S. Vayman, Z. Ying, F. Gomez-Pinilla, Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur. J. Neurosci. 20, 2580–2590 (2004)
157. K.A. Intlekofer, C.W. Cotman, Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol. Dis. 57, 47–55 (2013)
158. K.I. Erickson, M.W. Voss, R.S. Prakash, C. Basak, A. Szabo, L. Chaddock, J.S. Kim, S. Heo, H. Alves, S.M. White, T.R. Wojcicki, E. Mailey, V.J. Vieira, S.A. Martin, B.D. Pence, J.A. Woods, E. McAuley, A.F. Kramer, Exercise training increases size of hippocampus and improves memory. Proc. Natl Acad. Sci. USA 108, 3017–3022 (2011)
159. L.F. ten Brinke, N. Bolandzadeh, L.S. Nagamatsu, C.L. Hsu, J.C. Davis, K. Miran-Khan, T. Liu-Ambrose, Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial. Br. J. Sports Med. 49, 248–254 (2015)
160. S.R. Colberg, A.L. Albright, B.J. Blissmer, B. Braun, L. Chasan-Taber, B. Fernhall, J.G. Regensteiner, R.R. Rubin, R.J. Sigal, American College of Sports Medicine; American Diabetes Association. Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med. Sci. Sports Exerc. 42, 2282–2303 (2010)